ST-segment elevation myocardial infarction (STEMI)

This current study explored the effect of heavy particle pollution on total cardiovascular admissions, whilst also looking at risk for specific cardiovascular diagnoses, such as angina, myocardial infarction, and ischaemic stroke.

A 70-year-old gentleman with background of hypertension and smoking presented with STEMI. Coronary angiogram showed ectasia in the mid and distal segment with heavy thrombus burden.

This study aimed to increase the power to detect differences in patient survival (freedom from cardiac deaths) with IVUS versus angiography guidance by pooling the individual patient data from the IVUS-XPL and ULTIMATE trials.

In this prespecified subgroup analysis of the TWILIGHT trial, the authors report the impact of prior MI on treatment effects of ticagrelor monotherapy compared to ticagrelor and aspirin in patients at least three months post PCI...

In this session, five challenging STEMI cases are discussed so as to enable you to find out how to manage complex primary PCI in STEMI with multivessel disease (MVD).

Thanks to the 3 presentations proposed in this session, review SCAI classification of cardiogenic shock and appraise the role of MCS in the management of STEMI with cardiogenic shock in the cathlatb.

Watch this session to discover a selection of STEMI cases presented at GulfPCR-GIM 2021, and learn more about: the treatment of intramural haematoma and AMI, the role of plaque modifying device in ACS, the therapeutic strategy for a pan-coronary vulnerability, the importance of stent visualisation to improve...

Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.

The FUTURE Trial is a prospective randomised, multicentre, open label superiority trial comparing an FFR guided treatment strategy to traditional angiography guided treatment strategy on clinical outcomes in an all-comer population with multivessel coronary artery disease.

Elad Asher reviews the EROSION III trial, presented by Haibo Jia, which studied whether OCT guidance compared with angiographic guidance only is associated with lower stent rate implantation during pPCI in STEMI patients with non-obstructive stenosis.